You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study
|
|---|---|
| Published in |
European Heart Journal, June 2012
|
| DOI | 10.1093/eurheartj/ehs149 |
| Pubmed ID | |
| Authors |
Elisabet Nikolic, Magnus Janzon, Ole Hauch, Lars Wallentin, Martin Henriksson |
| Abstract |
The efficacy and safety of ticagrelor vs. clopidogrel in patients with acute coronary syndromes (ACS) are well documented in the PLATelet inhibition and patient Outcomes trial (PLATO). The aim of this study was to assess the long-term cost-effectiveness of treating ACS patients for 12 months with ticagrelor compared with generic clopidogrel. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 33% |
| United Kingdom | 1 | 8% |
| India | 1 | 8% |
| Saudi Arabia | 1 | 8% |
| Canada | 1 | 8% |
| Unknown | 4 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 58% |
| Practitioners (doctors, other healthcare professionals) | 3 | 25% |
| Scientists | 1 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Sweden | 3 | 2% |
| Spain | 1 | <1% |
| Turkey | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 118 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 18 | 15% |
| Other | 15 | 12% |
| Researcher | 14 | 11% |
| Student > Ph. D. Student | 10 | 8% |
| Student > Doctoral Student | 8 | 6% |
| Other | 32 | 26% |
| Unknown | 27 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 59 | 48% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 8% |
| Economics, Econometrics and Finance | 9 | 7% |
| Agricultural and Biological Sciences | 4 | 3% |
| Nursing and Health Professions | 4 | 3% |
| Other | 7 | 6% |
| Unknown | 31 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2020.
All research outputs
#2,433,721
of 25,371,288 outputs
Outputs from European Heart Journal
#3,075
of 11,048 outputs
Outputs of similar age
#14,917
of 177,907 outputs
Outputs of similar age from European Heart Journal
#10
of 95 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,048 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.6. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,907 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.